Ms. Julia J Polansky, MSW LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 230 Maple St, Suite B, Holyohe, MA 01040 Phone: 413-532-9446 |
News Archive
Professors of Medicine Degree at the CEU Cardenal Herrera University and the Provincial Hospital of Castellón, in collaboration with doctors of the Addictive Behaviors Unit of Valencia, have described the first case of catatonic psychosis caused by a synthetic derivate of Cannabis: the spice.
Traumatic brain injury can cause post-traumatic neurodegenerations with an increase in reactive oxygen species and reactive oxygen species-mediated lipid peroxidation. Melatonin, a non-enzymatic antioxidant and neuroprotective agent, has been shown to counteract oxidative stress-induced pathophysiologic conditions like cerebral ischemia/reperfusion injury, neuronal excitotoxicity and chronic inflammation.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
Unprecedented collaboration and resources will be required to research and develop safe and effective vaccines for COVID-19 that can be manufactured and delivered in the scale of billions of doses to people globally.
At a press conference held at the Montreal Heart Institute (MHI) this morning, Dr. Michel Carrier, cardiac surgeon, and Dr. Normand Racine, cardiologist and Head of the Department of Medicine, along with Robert Busilacchi, Executive Director, gave an update on the current situation in cardiac surgery at the Institute.
› Verified 5 days ago